Navigation Links
Discovery may lead to new treatments for allergic diseases
Date:11/11/2013

A collaboration among researchers in Israel and the United States has resulted in the discovery of a new pathway that has broad implications for treating allergic diseases particularly eosinophil-associated disorders.

The researchers from Tel Aviv University and Cincinnati Children's Hospital Medical Center have discovered how this pathway kills eosinophils before they can cause havoc. Eosinophils are normal cellular components of the blood, but when the body produces too many eosinophils they can cause a variety of eosinophilic disorders. These are disorders involving chronic inflammation resulting in tissue damage, often in the gastrointestinal system.

The study is published online in the journal Nature Immunology.

"The fundamental knowledge we have gained may one day yield new therapies to treat devastating eosinophilic disorders," says Ariel Munitz, PhD, a researcher at the department of Clinical Microbiology and Immunology at the Sackler School of Medicine at Tel Aviv University and corresponding author of the study.

Eosinophils are regulated by interleukin 5 (IL-5), a protein that triggers eosinophils to leave the bone marrow and enter the bloodstream, where they can reach various organs. Dr. Munitz and Marc Rothenberg, MD, PhD, director of Allergy and Immunology at Cincinnati Children's, have identified a pathway for counterbalancing what happens when IL-5 triggers eosinophils. The newly identified pathway involves a key checkpoint controlled by a pair of proteins, PIR-A and PIR-B, which the researchers now show have a critical role in eosinophil development.

PIR-A induces eosinophils to die and thus is in a perpetual tug-of-war with survival and growth signals driven by IL-5. The researchers discovered that PIR-A is dominant in this battle but that cell death doesn't occur because PIR-B inhibits its actions. For PIR-A to win the battle and cause cells to die, PIR-B must be shut down.

The researchers studied asthmatic mice and discovered that asthmatic mice without PIR-B had little expansion of eosinophils in their blood and lungs and less asthmatic inflammation in their lungs than normal mice. The lack of PIR-B kept eosinophils from reaching harmful levels. The researchers hope that scientists can now target PIR-A to enhance its ability to kill eosinophils or weaken PIR-B so that it inhibits PIR-A to a lesser extent.


'/>"/>

Contact: Nick Miller
nicholas.miller@cchmc.org
513-803-6035
Cincinnati Children's Hospital Medical Center
Source:Eurekalert

Related biology news :

1. International collaboration finds 11 new Alzheimers genes to target for drug discovery
2. McGill discovery should save wheat farmers millions of dollars
3. New genetic discovery could reduce the guesswork in drug dosing
4. Decades on, bacteriums discovery feted as paragon of basic science
5. Discovery of cell division master controller may improve understanding and treatment of cancer
6. Discovery about DNA repair could lead to improved cancer treatments
7. Discovery helps to unlock brains speech-learning mechanism
8. University of Hawaii Cancer Center researchers discovery
9. 4 projects awarded Discovery Transformation Grant funding by Minnesota Partnership
10. NOAA reports discovery of table coral, Acropora cytherea, off Oahu
11. UK researcher earns 2013 Discovery Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2018)... ... 28, 2018 , ... Today, Bright Computing , a ... Science Technologies has implemented Bright Cluster Manager at the HudsonAlpha Institute for Biotechnology. ... and genetics research institute located in Huntsville, Ala. Its mission is four-fold: genomic ...
(Date:8/26/2018)... ... August 24, 2018 , ... ... in clinical diagnostic laboratories. However, this technology introduces many well-described challenges around ... which leads the South London NHS Genomic Medicine Centre. The Viapath Genetics ...
(Date:8/23/2018)... ... August 22, 2018 , ... Lajollacooks4u is proud to have hosted a variety of ... time. Companies, such as Illumina, Qualcomm, Hewlett Packard, Sequenom and more, have all visited ... teams. , Part of the reason clientele return is due to Lajollacooks4u’s signature ...
Breaking Biology News(10 mins):
(Date:9/7/2018)... (PRWEB) , ... September 05, 2018 , ... Now available ... Systems will be held on Sept. 19, 2018. With a panel of industry leaders ... this exciting event will reveal industry insights from experts in the field. Register ...
(Date:9/7/2018)... Mass. (PRWEB) , ... September 06, 2018 , ... ... medical device compliance and commercialization, is releasing the agenda for its upcoming user ... across life science industries discussing the latest challenges, opportunities, and approaches to regulatory ...
(Date:9/7/2018)... ... September 06, 2018 , ... Akadeum Life Sciences today announced it has appointed ... executive and leader of numerous biotech companies. , He most recently served as ... by Thompson Street Capital in St. Louis, MO. Prior to ISTO, he was ...
(Date:8/31/2018)... ... August 29, 2018 , ... ... both the University of Southampton and the Institute of Industrial Science, the University ... sea can dramatically accelerate the exploration and study of hard to reach deep ...
Breaking Biology Technology: